1. Home
  2. VNDA vs COFS Comparison

VNDA vs COFS Comparison

Compare VNDA & COFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • COFS
  • Stock Information
  • Founded
  • VNDA 2002
  • COFS 1898
  • Country
  • VNDA United States
  • COFS United States
  • Employees
  • VNDA N/A
  • COFS N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • COFS Major Banks
  • Sector
  • VNDA Health Care
  • COFS Finance
  • Exchange
  • VNDA Nasdaq
  • COFS Nasdaq
  • Market Cap
  • VNDA 270.2M
  • COFS 322.9M
  • IPO Year
  • VNDA 2006
  • COFS N/A
  • Fundamental
  • Price
  • VNDA $4.94
  • COFS $36.50
  • Analyst Decision
  • VNDA Strong Buy
  • COFS Strong Buy
  • Analyst Count
  • VNDA 2
  • COFS 1
  • Target Price
  • VNDA $15.50
  • COFS $37.00
  • AVG Volume (30 Days)
  • VNDA 643.5K
  • COFS 35.0K
  • Earning Date
  • VNDA 11-06-2024
  • COFS 10-23-2024
  • Dividend Yield
  • VNDA N/A
  • COFS 3.01%
  • EPS Growth
  • VNDA N/A
  • COFS 5.14
  • EPS
  • VNDA N/A
  • COFS 3.16
  • Revenue
  • VNDA $190,858,000.00
  • COFS $87,896,000.00
  • Revenue This Year
  • VNDA $5.13
  • COFS N/A
  • Revenue Next Year
  • VNDA $42.65
  • COFS $77.96
  • P/E Ratio
  • VNDA N/A
  • COFS $11.32
  • Revenue Growth
  • VNDA N/A
  • COFS 8.01
  • 52 Week Low
  • VNDA $3.46
  • COFS $21.52
  • 52 Week High
  • VNDA $6.75
  • COFS $37.00
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 50.36
  • COFS 72.31
  • Support Level
  • VNDA $4.82
  • COFS $35.10
  • Resistance Level
  • VNDA $5.55
  • COFS $36.44
  • Average True Range (ATR)
  • VNDA 0.22
  • COFS 0.76
  • MACD
  • VNDA -0.02
  • COFS 0.01
  • Stochastic Oscillator
  • VNDA 32.22
  • COFS 89.25

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

About COFS ChoiceOne Financial Services Inc.

ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.

Share on Social Networks: